NDC 15631-0532

BADIAGA

Badiaga

BADIAGA is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Spongilla Lacustris.

Product ID15631-0532_41e661bd-1448-4d82-9e58-fc1d2cdba360
NDC15631-0532
Product TypeHuman Otc Drug
Proprietary NameBADIAGA
Generic NameBadiaga
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-12-30
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameSPONGILLA LACUSTRIS
Active Ingredient Strength2 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0532-7

10000 TABLET in 1 CONTAINER (15631-0532-7)
Marketing Start Date2015-12-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0532-7 [15631053207]

BADIAGA TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0532-3 [15631053203]

BADIAGA TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0532-2 [15631053202]

BADIAGA TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0532-6 [15631053206]

BADIAGA TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0532-0 [15631053200]

BADIAGA TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0532-1 [15631053201]

BADIAGA TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0532-4 [15631053204]

BADIAGA TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0532-5 [15631053205]

BADIAGA TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
SPONGILLA LACUSTRIS2 [hp_X]/1

OpenFDA Data

SPL SET ID:b0f08bc2-db33-4ee7-8ac5-c7ceedcae1d0
Manufacturer
UNII
UPC Code
  • 8907460005526
  • NDC Crossover Matching brand name "BADIAGA" or generic name "Badiaga"

    NDCBrand NameGeneric Name
    0220-0759BadiagaSPONGILLA LACUSTRIS
    0220-0761BadiagaSPONGILLA LACUSTRIS
    15631-0070BADIAGABADIAGA
    15631-0532BADIAGABADIAGA
    63545-345BadiagaBadiaga
    63545-346BadiagaBadiaga
    63545-347BadiagaBadiaga
    63545-348BadiagaBadiaga
    63545-349BadiagaBadiaga
    63545-350BadiagaBadiaga
    63545-351BadiagaBadiaga
    68428-246BadiagaSPONGILLA LACUSTRIS
    71919-107BadiagaSPONGILLA LACUSTRIS

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.